Publication | Closed Access

Novel protein kinase cAMP-Activated Catalytic Subunit Alpha (PRKACA) inhibitor shows anti-tumor activity in a fibrolamellar hepatocellular carcinoma model

Cancer ResearchMedicinePathologyProtein PhosphorylationTumor SuppressorAnti-tumor ActivityCancer BiologyCell BiologyCell SignalingTumor Biology